rhodamine 123 has been researched along with Hematologic Malignancies in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Halliday, GM; Ishri, RK; Menzies, S | 1 |
| Kobayashi, H; Takemura, Y | 1 |
| Gualde, N; Huet, S; Marie, JP; Robert, J | 1 |
1 review(s) available for rhodamine 123 and Hematologic Malignancies
| Article | Year |
|---|---|
[Quantitative analysis of multidrug resistance phenotype in hematological malignancies].
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Drug Resistance, Multiple; Fluorescent Dyes; Hematologic Neoplasms; Humans; Phenotype; Polymerase Chain Reaction; Rhodamine 123; Rhodamines; RNA, Messenger | 1998 |
2 other study(ies) available for rhodamine 123 and Hematologic Malignancies
| Article | Year |
|---|---|
Verapamil induces upregulation of P-glycoprotein expression on human monocyte derived dendritic cells.
Topics: Antibodies, Monoclonal; ATP Binding Cassette Transporter, Subfamily B, Member 1; Calcium Channel Blockers; Cell Differentiation; Cell Line, Tumor; Dendritic Cells; Hematologic Neoplasms; Humans; Macrophages; Monocytes; Rhodamine 123; Streptococcus pyogenes; Up-Regulation; Verapamil | 2006 |
Reference method for detection of Pgp mediated multidrug resistance in human hematological malignancies: a method validated by the laboratories of the French Drug Resistance Network.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line; Drug Resistance, Multiple; Evaluation Studies as Topic; Flow Cytometry; Hematologic Neoplasms; Humans; Reference Standards; Reproducibility of Results; Rhodamine 123 | 1998 |